Literature DB >> 20682307

Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats.

Henry A Nasrallah1, Tracy Hopkins, Sarah K Pixley.   

Abstract

Increased neurogenesis in the hippocampus and subventricular zone (SVZ) of the brain of animals has been demonstrated following administration of several psychotropic medications. Such changes are thought to regenerate tissues and contribute to the beneficial effects of the medications. This study sought to determine if another neurogenic tissue, the peripheral olfactory epithelium (OE), might also exhibit changes after treatment with psychotropic medications. Young adult male rats were treated with risperidone and paliperidone, atypical antipsychotic medications; fluoxetine, a selective serotonin reuptake inhibitor (SSRI) antidepressant; and diluent control for 28days via drinking water. Bromodeoxyuridine (BrdU) was injected to label dividing cells and positive cells were quantified in the OE, cortical SVZ, and dentate gyrus (DG) of the hippocampus. In the first of two studies, paliperidone and risperidone treatment (at 1mg/kg/day) resulted in increased numbers over controls of BrdU positive cells in the OE. In the second study, examining OE, SVZ and DG in the same animal, paliperidone, but not risperidone or fluoxetine (0.6 mg/kg/day) resulted in increased cells in the OE and posterior SVZ. However, fluoxetine, but not paliperidone or risperidone treatment increased BrdU positive cells in the DG. These results show that psychotropic drug-induced cell proliferation occurs in the OE and parallels changes in the SVZ but not DG. Thus, the peripheral OE can serve as a proxy for certain psychotropic drug-induced actions on SVZ brain cell proliferation. This olfactory model can be employed in human research as a method to explore the neurogenesis effects of various pharmacologic treatments of neuropsychiatric disorders. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682307     DOI: 10.1016/j.brainres.2010.07.075

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

Review 1.  Depression, antidepressants, and neurogenesis: a critical reappraisal.

Authors:  Nicola D Hanson; Michael J Owens; Charles B Nemeroff
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

Review 2.  Synapsin III: role in neuronal plasticity and disease.

Authors:  Barbara Porton; William C Wetsel; Hung-Teh Kao
Journal:  Semin Cell Dev Biol       Date:  2011-07-30       Impact factor: 7.727

Review 3.  Wnt signaling in neuropsychiatric disorders: ties with adult hippocampal neurogenesis and behavior.

Authors:  Syed Mohammed Qasim Hussaini; Chan-Il Choi; Chang Hoon Cho; Hyo Jin Kim; Heechul Jun; Mi-Hyeon Jang
Journal:  Neurosci Biobehav Rev       Date:  2014-09-28       Impact factor: 8.989

4.  Hippocampus and cognitive domain deficits in treatment-resistant schizophrenia: A comparison with matched treatment-responsive patients and healthy controls✰,✰✰,★,★★.

Authors:  Junchao Huang; Yu Zhu; Fengmei Fan; Song Chen; Yuan Hong; Yimin Cui; Xingguang Luo; Shuping Tan; Zhiren Wang; Lan Shang; Ying Yuan; Jianxin Zhang; Fude Yang; Chiang-Shan R Li; Laura M Rowland; Peter Kochunov; Fengyu Zhang; L Elliot Hong; Yunlong Tan
Journal:  Psychiatry Res Neuroimaging       Date:  2020-02-04       Impact factor: 2.376

5.  Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice.

Authors:  Koji Ohira; Tsuyoshi Miyakawa
Journal:  Mol Brain       Date:  2011-03-08       Impact factor: 4.041

6.  NeuN+ neuronal nuclei in non-human primate prefrontal cortex and subcortical white matter after clozapine exposure.

Authors:  Tobias B Halene; Alexey Kozlenkov; Yan Jiang; Amanda C Mitchell; Behnam Javidfar; Aslihan Dincer; Royce Park; Jennifer Wiseman; Paula L Croxson; Eustathia Lela Giannaris; Patrick R Hof; Panos Roussos; Stella Dracheva; Scott E Hemby; Schahram Akbarian
Journal:  Schizophr Res       Date:  2016-01-06       Impact factor: 4.939

7.  Ketamine exposure during embryogenesis inhibits cellular proliferation in rat fetal cortical neurogenic regions.

Authors:  C Dong; C R Rovnaghi; K J S Anand
Journal:  Acta Anaesthesiol Scand       Date:  2016-01-29       Impact factor: 2.105

8.  Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI Study.

Authors:  Sidhant Chopra; Alex Fornito; Shona M Francey; Brian O'Donoghue; Vanessa Cropley; Barnaby Nelson; Jessica Graham; Lara Baldwin; Steven Tahtalian; Hok Pan Yuen; Kelly Allott; Mario Alvarez-Jimenez; Susy Harrigan; Kristina Sabaroedin; Christos Pantelis; Stephen J Wood; Patrick McGorry
Journal:  Neuropsychopharmacology       Date:  2021-02-26       Impact factor: 7.853

9.  Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis.

Authors:  Ramon Guirado; David Sanchez-Matarredona; Emilo Varea; Carlos Crespo; José Miguel Blasco-Ibáñez; Juan Nacher
Journal:  BMC Neurosci       Date:  2012-01-05       Impact factor: 3.288

10.  New model of action for mood stabilizers: phosphoproteome from rat pre-frontal cortex synaptoneurosomal preparations.

Authors:  Maria Corena-McLeod; Consuelo Walss-Bass; Alfredo Oliveros; Andres Gordillo Villegas; Carolina Ceballos; Cristine M Charlesworth; Benjamin Madden; Paul J Linser; Leslie Van Ekeris; Kristin Smith; Elliott Richelson
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.